Published in
Elsevier, International Journal of Cardiology, 3(176), p. 1113-1115, 2014
DOI: 10.1016/j.ijcard.2014.07.106
Links
Tools
Evaluation of the clinical use of midregional pro-atrial natriuretic peptide (MR-proANP) in comparison to N-terminal pro-B-type natriuretic peptide (NT-proBNP) for risk stratification in patients with light-chain amyloidosis
Journal article published in 2014 by
Arnt V. Kristen 
,
Moritz Biener,
Ute Hegenbart,
Stefan Hardt,
Philipp A. Schnabel,
Christoph Röcken,
Hugo A. Katus,
Stefan O. Schonland ,
Evangelos Giannitsis
,
Moritz Biener,
Ute Hegenbart,
Stefan Hardt,
Philipp A. Schnabel,
Christoph Röcken,
Hugo A. Katus,
Stefan O. Schonland ,
Evangelos Giannitsis
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 